Successful treatment of congenital systemic juvenile xanthogranuloma with Langerhans cell histiocytosis-based chemotherapy

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 6, 2004, Pages 371-374

  Nakatani, Takuya ^a   Morimoto, Akira ^a   Kato, Ryuichi ^a   Tokuda, Sachiko ^a   Sugimoto, Tohru ^a   Tokiwa, Kazuaki ^a   Tsuchihashi, Yasunari ^a   Imashuku, Shinsaku ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Kyoto City Institute of Health and Environmental Sciences   (Japan)

Author keywords

Central nervous system lesions; Congenital systemic juvenile xanthogranuloma; Langerhans cell histiocytosis; Multiagent chemotherapy

Indexed keywords

CYTARABINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ARTICLE; BLOOD CLOTTING DISORDER; BRAIN TUMOR; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHEMOTHERAPY; CONGENITAL SYSTEMIC JUVENILE XANTHOGRANULOMA; FEMALE; FETUS ECHOGRAPHY; HEPATOMEGALY; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; HUMAN CELL; JUVENILE XANTHOGRANULOMA; LIVER DYSFUNCTION; MULTIPLE CANCER; NEWBORN; NEWBORN DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; SKIN MANIFESTATION; SPLENOMEGALY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; TREATMENT OUTCOME; XANTHOGRANULOMA, JUVENILE;

EID: 2942530447     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200406000-00007     Document Type: Article

References (10)

1. Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol. 1997;29:157-166.
2. Freyer DR, Kennedy R, Bostrom BC, et al. Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr. 1996;129:227-237.
3. Dehner LP. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol. 2003;27:579-593.
4. Bostrom J, Janssen G, Messing-Junger M, et al. Multiple intracranial juvenile xanthogranulomas. J Neurosurg. 2000;93:335-341.
5. Ikushima S, Kinugawa N, Hibi S, et al. Multiinstitutional trial in the treatment of pediatric patients with Langerhans cell histiocytosis: therapeutic results treated by Protocol JLSG-96. Jpn J Pediatr Hematol. 2002;16:135-142.
6. Sangueza OP, Salmon JK, White CR, et al. Juvenile xanthogranuloma: a clinical, histopathological, and immunohistochemical study. J Cutan Pathol. 1995;22:327-335.
7. Kraus MD, Haley JC, Ruiz R, et al. Juvenile xanthogranuloma: an immunophenotypic study with a reappraisal of histiogenesis. Am J Dermatopathol. 2001;23:104-111.
8. Tomaszewski MM, Lupton GP. Unusual expression of S-100 protein in histiocytic neoplasms. J Cutan Pathol. 1998;25:129-135.
9. Caputo R, Ermacora E, Gelmetti C, et al. Fatal nodular xanthomatosis in an infant. Pediatr Dermatol. 1987;4:242-246.
10. Flach DB, Winkelmann RK. Juvenile xanthogranuloma with central nervous system lesions. J Am Acad Dermatol. 1986;14:405-411.